Terns Pharmaceuticals Statistics Share Statistics Terns Pharmaceuticals has 87.51M
shares outstanding. The number of shares has increased by 3.44%
in one year.
Shares Outstanding 87.51M Shares Change (YoY) 3.44% Shares Change (QoQ) 0.05% Owned by Institutions (%) 90.86% Shares Floating 69.58M Failed to Deliver (FTD) Shares 562 FTD / Avg. Volume 0.05%
Short Selling Information The latest short interest is 8.31M, so 9.49% of the outstanding
shares have been sold short.
Short Interest 8.31M Short % of Shares Out 9.49% Short % of Float 9.5% Short Ratio (days to cover) 6.72
Valuation Ratios The PE ratio is -4.96 and the forward
PE ratio is -5.9.
Terns Pharmaceuticals's PEG ratio is
0.42.
PE Ratio -4.96 Forward PE -5.9 PS Ratio 0 Forward PS 626.8 PB Ratio 1.27 P/FCF Ratio -6.29 PEG Ratio 0.42
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Terns Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 23.14,
with a Debt / Equity ratio of 0.
Current Ratio 23.14 Quick Ratio 23.14 Debt / Equity 0 Debt / EBITDA -0.02 Debt / FCF -0.02 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.51M Employee Count 59 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 260K Effective Tax Rate -0.29%
Stock Price Statistics The stock price has increased by -10.64% in the
last 52 weeks. The beta is -0.05, so Terns Pharmaceuticals's
price volatility has been lower than the market average.
Beta -0.05 52-Week Price Change -10.64% 50-Day Moving Average 6.73 200-Day Moving Average 4.66 Relative Strength Index (RSI) 56.32 Average Volume (20 Days) 1,073,914
Income Statement
Revenue n/a Gross Profit n/a Operating Income -101.87M Net Income -88.85M EBITDA -87.7M EBIT -88.59M Earnings Per Share (EPS) -1.12
Full Income Statement Balance Sheet The company has 161.44M in cash and 1.35M in
debt, giving a net cash position of 160.09M.
Cash & Cash Equivalents 161.44M Total Debt 1.35M Net Cash 160.09M Retained Earnings -421.48M Total Assets 320.42M Working Capital 306.04M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -70.02M
and capital expenditures -42K, giving a free cash flow of -70.06M.
Operating Cash Flow -70.02M Capital Expenditures -42K Free Cash Flow -70.06M FCF Per Share -0.88
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
